Moderna’s mRNA Candidate Joins FDA’s Accelerator Program for Rare Diseases

Moderna’s mRNA Candidate Joins FDA’s Accelerator Program for Rare Diseases

Submitted by admin on June 6, 2024 - 11:39am
Source: 
BioSpace
News Tags: 
Moderna Therapeutics
mRNA-3705
FDA
Rare Diseases
START
Headline: 
Moderna’s mRNA Candidate Joins FDA’s Accelerator Program for Rare Diseases
snippet: 

Moderna on Thursday announced that the FDA has selected its investigational methylmalonic acidemia therapy mRNA-3705 for the agency’s Support for Clinical Trials Advancing Rare Disease Therapeutics pilot program.

Do Not Allow Advertisers to Use My Personal information